Aspen is expected to receive another $75 million, which will be held in escrow, upon satisfaction of certain conditions. Arixtra is approved for the treatment of deep vein thrombosis (DVT.V), which ...

Mylan Inc. ( MYL) is all set to acquire the U.S. commercialization, marketing and intellectual property rights to Arixtra injection from Aspen Global Incorporated for $225 million (initial payment).

Mylan Inc's subsidiary Mylan Ireland Limited has entered into an agreement to acquire the US commercialization, marketing and intellectual property rights relating to Arixtra (fondaparinux sodium) ...

UK drugmaker GlaxoSmithKline’s blood-thinner Arixtra (fondaparinux sodium) can cut patients’ risk of forming venous blood clots by nearly half, according to a study published in the February 11 ...

June 9, 2005 — The U.S. Food and Drug Administration (FDA) has approved a capsule formulation of paricalcitol for the prevention and treatment of secondary hyperparathyroidism in patients with stage ...

July 18, 2005 -- Health Canada has approved erlotinib tablets as monotherapy for locally advanced or metastatic non-small cell lung cancer (NSCLC) after failure of at least one prior chemotherapy ...

GlaxoSmithKline Receives Approvable Letter For New Indications For ARIXTRA(R)(Fondaparinux Sodium) Injection PHILADELPHIA, Feb. 2 -- GlaxoSmithKline (GSK) announced today that the U.S. Food and Drug ...

PITTSBURGH, Sept. 10, 2014 /PRNewswire/ -- Mylan Inc. today announced that its subsidiary Mylan Ireland Limited has entered into an agreement to acquire the U.S. commercialization, marketing and ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Fondaparinux (Arixtra 2.5mg) is an anticoagulant ...